Oncology Reports is a distinguished journal dedicated to advancing knowledge in the field of oncology. Published by Spandidos Publications Ltd, this journal has been a cornerstone in cancer research since its establishment in 1994 and is set to continue its impactful contributions until 2024. With ISSN 1021-335X and E-ISSN 1791-2431, it ranks in the Q2 category in Cancer Research, Medicine (Miscellaneous), and Oncology as of 2023, reflecting its solid standing in the academic community. The journal's current Scopus rankings position it notably within Medicine (Oncology) (#74/404, 81st percentile) and Biochemistry, Genetics and Molecular Biology (Cancer Research) (#67/230, 71st percentile), underscoring its rigorous peer-review process and the quality of its published research. Although not an open-access journal, Oncology Reports remains committed to disseminating vital information to researchers, professionals, and students, ensuring they stay at the forefront of developments in cancer studies. Its comprehensive scope promotes a multidisciplinary approach, encompassing clinical and experimental aspects of oncology, thus serving as an essential resource for those striving to understand and combat cancer.

JNCI Cancer Spectrum, published by Oxford University Press, is a leading open-access journal dedicated to advancing the field of cancer research and oncology. With an impressive impact demonstrated through its Q1 ranking in both Cancer Research and Oncology categories for 2023, this journal provides a vital platform for disseminating high-quality research and innovative findings in a rapidly evolving landscape. Since its inception in 2017, JNCI Cancer Spectrum has embraced open access, enhancing the accessibility of evidence-based knowledge to researchers, professionals, and students across the globe. Additionally, it boasts notable positions in Scopus rankings, with a strong performance in both the Medicine and Biochemistry, Genetics and Molecular Biology categories. The journal is committed to its objectives of fostering collaborative efforts and encouraging dialogue among experts, making it an essential resource for anyone involved in cancer research.

International Journal of Palliative Nursing is a renowned peer-reviewed journal dedicated to advancing the field of palliative care and nursing. Published by MA HEALTHCARE LTD in the United Kingdom, this journal has been a pivotal resource for healthcare professionals, researchers, and students alike since its inception in 2000. With an ISSN of 1357-6321, it is well-regarded for its commitment to high-quality research and practical insights, maintaining a Q3 category ranking in Advanced and Specialized Nursing. Despite its non-open access format, the journal offers a wealth of knowledge through a diverse array of articles that cover the latest advancements and best practices in palliative nursing. Its Scopus Rank at #36/63 reflects its respectable standing in the nursing community and highlights its contributions to the interdisciplinary realm of palliative care. The journal is an invaluable platform for fostering dialogue and sharing innovative approaches to nurture compassionate patient care.

Zeitschrift für Palliativmedizin, published by GEORG THIEME VERLAG KG, is a leading journal dedicated to the field of palliative medicine. With its focus on improving the quality of life for patients with severe illnesses, this journal serves as an essential platform for researchers, healthcare professionals, and students interested in the latest developments, practices, and innovations in palliative care. While it does not currently offer open access options, Zeitschrift für Palliativmedizin is committed to disseminating high-quality, peer-reviewed research that advances the understanding and implementation of palliative care strategies. Situated in Stuttgart, Germany, this journal aims to bridge the gap between clinical practice and research, facilitating the exchange of knowledge that enhances patient care and support. As the field continues to grow in importance, this journal stands out as an invaluable resource for those dedicated to improving patient outcomes and advancing the discourse in palliative medicine.

Current Oncology Reports is a prestigious academic journal dedicated to the field of oncology, published by Springer and based in the United States. With an impressive impact factor and ranking as a Q1 journal in the 2023 category of Oncology, it positions itself among the top-tier publications within the discipline. Established in 1999, the journal has been a vital resource for researchers, professionals, and students alike, providing comprehensive insights and the latest advancements in cancer research and treatment. Through its rigorous peer-review process, Current Oncology Reports disseminates high-quality original articles, reviews, and clinical studies that foster collaboration and innovation in the oncology community. Although it currently operates under a subscription model, the journal remains committed to accessibility, ensuring that critical findings reach a broad audience. As such, it serves as an essential platform for those dedicated to the fight against cancer, making significant contributions to the evolving landscape of oncology.

Onkologija is a distinguished open-access journal dedicated to the field of oncology, published by the Institute of Oncology Ljubljana. With its ISSN 1408-1741 and E-ISSN 1581-3215, this journal has become a crucial platform for researchers and healthcare professionals since its transition to open-access in 2008, allowing widespread dissemination of critical findings and innovations in cancer research and treatment. Located in Ljubljana, Slovenia, the journal aims to bridge the gap between clinical practice and research by publishing high-quality original articles, reviews, and case studies that address pivotal issues in oncology. Although specific metrics such as HIndex and Scopus ranks are currently unavailable, Onkologija’s commitment to advancing oncology knowledge is evident in its engaging publications that attract a diverse readership, making it an essential resource for anyone invested in the battle against cancer.

Medecine Palliative is a distinguished journal published by Elsevier, dedicated to the vital field of palliative care and pain management. With an ISSN of 1636-6522 and E-ISSN 2213-0098, this international journal has been an essential resource since its inception in 1970, currently covering research from 2004 to 2024. The journal reflects a commitment to enhancing the quality of life for patients facing serious illnesses, addressing critical issues in Anesthesiology and Oncology, while fostering innovative nursing practices in palliative care. While the journal holds a Q3 ranking in Anesthesiology and Pain Medicine and a Q4 in Oncology categories, making it a valuable venue for researchers and practitioners aiming to contribute to the evolving landscape of palliative medicine. Despite its lower rank in some categories, the journal serves as an important platform for insights, clinical findings, and current practices that can significantly impact patient care. Medecine Palliative is accessible to researchers, professionals, and students who are eager to explore the latest advancements and evidence-based approaches in end-of-life care.

Journal of Geriatric Oncology, published by Elsevier, stands at the intersection of geriatric medicine and oncology, addressing the unique needs and challenges of cancer management in older adults. Since its inception in 2010, this esteemed journal has played a pivotal role in advancing research and clinical practices, aiming to improve the quality of life and treatment outcomes for elderly cancer patients. With its impressive categorization in the 2023 Q2 quartile for both Geriatrics and Gerontology and Oncology, the journal demonstrates a noteworthy impact within its fields, ranking #153 out of 404 in Medicine – Oncology and #45 out of 116 in Medicine – Geriatrics and Gerontology. Researchers and healthcare professionals are encouraged to access critical insights through its rigorous peer-reviewed articles, which offer cutting-edge research findings and clinical applications. As the field continues to evolve, the Journal of Geriatric Oncology remains a vital resource for those dedicated to fostering innovation in geriatric oncology.

CLINICS IN GERIATRIC MEDICINE, published by W B SAUNDERS CO-ELSEVIER INC, is a highly regarded journal in the field of geriatric medicine, with an impressive impact factor that underscores its significance in advancing the understanding of health issues among the elderly. Since its inception in 1985, the journal has served as a crucial resource for researchers, healthcare professionals, and students dedicated to improving geriatric care. As recognized leaders in the field, this journal is positioned in the Q1 quartile for Geriatrics and Gerontology, ranking #22 out of 116 in Scopus, placing it within the 81st percentile for scholarly impact. Although it is not an open-access publication, it provides unparalleled insights into current research trends, clinical practices, and innovative solutions for geriatric challenges. This comprehensive platform is essential for those committed to enhancing the quality of life for older adults and shaping the future of geriatric medicine.

JOURNAL OF PALLIATIVE CARE is a premier publication in the field dedicated to advancing the understanding and practice of palliative care. Published by SAGE Publications Inc, this journal serves as a vital platform for researchers, healthcare professionals, and students who are at the forefront of improving patient quality of life across various medical contexts. Since its inception, the journal has provided a rich repository of interdisciplinary research and insightful articles, addressing essential topics such as pain management, end-of-life care, and psychological support. With a respectable impact factor and a Q3 quartile ranking in the miscellaneous medicine category, it reflects the growing importance of palliative care in contemporary healthcare. The journal covers pivotal research from 1985 to 2015 and 2017 to 2024, underscoring its commitment to fostering a well-rounded discourse within the medical community. Researchers seeking to contribute to the field will find this journal an invaluable resource for disseminating cutting-edge findings and practical applications.